Submissions

In keeping with the mission of the FDA Center for Drug Evaluation and Research’s Office of Surveillance and Epidemiology Division of Medication Error and Prevention Analysis, this CHPA member feedback is designed to minimize the risk of medication errors due to consumer confusion attributed to an OTC drug product name.

CHPA is writing to request that FDA exercise its enforcement discretion and not take enforcement action against companies choosing to include a warning related to pregnancy on monograph product labels.

The American Cleaning Institute (ACI) and the Consumer Healthcare Products Association (CHPA) request that FDA withdraw its Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19).

Supply chain resilience is essential to assure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises.

The breadth of the proposed rule would create a heavy workload on agencies within HHS, diverting attention from more pressing work. CHPA requests an extension of the comment period

Enclosed are comments on the recent notice from the California Office of Environmental Health Hazard Assessment regarding 22 chemicals to be discussed at a meeting of the Developmental and Reproductive Toxicant Identification Committee. These comments address manganese.

These comments address the four parabens that are on the prioritization list. As these ingredients serve an important preservative function and have been extensively reviewed and approved by expert bodies, they should be considered low priority for DARTIC review.

These comments address titanium dioxide nanoparticles, which serve an important function in numerous consumer products, including sunscreens.

As FDA is recognized as an authoritative body by Proposition 65, we believe that OEHHA should await the outcome of FDA's review rather than bringing BP-3 to the DARTIC for review.

Enclosed are comments regarding the OEHHA draft report entitled " Health Effects Assessment: Potential Neurobehavioral Effects of Synthetic Food Dyes in Children."